Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© ERS 2020. Ethical and practical reasons often restrict the use of human cells and tissues in pre-clinical studies; therefore, investigators employ research laboratory models. In vitro and in vivo models are essential and indispensable for the study of pleural diseases as they provide a simplified network of the human biology and can also replicate features of the human condition. Despite their simplicity, laboratory models provide major contributions towards our understanding of pleural diseases and have led to the discovery of perturbated molecular pathways and mechanisms. There are various available in vitro and in vivo models of pleural disease, each with their own strengths and limitations. Therefore, experimental assays have to be carefully designed and implemented to avoid data misinterpretation. Technological advances have improved the efficiency and potency of laboratory models and have introduced new research techniques. Thus, in vitro and in vivo models provide an effective pre-clinical research tool to elucidate pleural disease pathogenesis and progression.

Original publication

DOI

10.1183/2312508X.10032719

Type

Journal article

Journal

ERS Monograph

Publication Date

01/01/2020

Volume

2020

Pages

29 - 47